Take a look at what our invited speakers have published recently and chat with them about their work in Ghent at our symposium.
Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype
Pembrolizumab versus Ipilimumab in Advanced Melanoma.
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive >melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Charles W. M. Roberts
SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2.
Monitoring immune responses in the tumor microenvironment.
Clinical Implications of Genomic Discoveries in Lung Cancer.
Microbiome and Anticancer Immunosurveillance